Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Clinical trial NCT06597006 · RECRUITING
Trial details
- NCT number
- NCT06597006
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2028-03-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.